The TB GOLD Test is an advanced diagnostic tool that uses an interferon-gamma release assay (IGRA) to detect latent tuberculosis infection.

Unlike the tuberculin skin test (TST), the TB GOLD Test does not require a return visit for reading and provides more accurate results by measuring the immune response to TB-specific antigens.

No special preparation is required. You can eat and drink normally before the test, but inform your healthcare provider about any medications or recent illnesses.

Results are typically available within 2 to 7 days after the sample is analyzed in the laboratory.

The TB GOLD Test helps accurately diagnose latent TB infection, which is crucial for preventing the progression to active TB and ensuring appropriate treatment and management.

It measures various lipids in the blood, including cholesterol and triglycerides, to assess cardiovascular risk.

Yes, fasting for 9-12 hours is generally required to obtain accurate fasting cholesterol levels.

It helps evaluate cardiovascular risk, diagnose lipid disorders, and monitor treatment effectiveness.

The frequency depends on individual risk factors and healthcare provider recommendations. Generally, it is recommended every 4-6 years for adults, more frequently for those with risk factors.

The Widal test involves collecting a blood sample and testing it for antibodies against Salmonella typhi and related serotypes.

No, the Widal test specifically detects antibodies against Salmonella typhi and is not used to diagnose other infections.

Positive results indicate exposure to Salmonella typhi, suggesting current or past infection, while negative results indicate no significant antibody response.

Recent vaccination against typhoid fever or certain medications may interfere with the accuracy of Widal test results.

The Widal test provides supportive evidence for diagnosing typhoid fever but is often used in conjunction with clinical symptoms and other diagnostic tests for confirmation.